Varicella vaccination in Hungary and Poland: optimization of public benefits from prophylaxis technologies in the time of austerity
Journal Title: New Medicine - Year 2013, Vol 17, Issue 3
Abstract
As an international collaboration between the Hungarian Pediatric Society and the Polish Foundation for the Development of Paediatrics, multidisciplinary expert group meeting was organized to analyze the current situation and the results of the work performed on varicella prevention in Poland and in Hungary (ie. burden of disease, public health considerations of primary preventive technologies), and to discuss the possible modification in vaccination practice based on the US and German experience and health economic considerations. Varicella (chickenpox) is a highly contagious disease predominantly affecting children aged 1-9 years, and approximately 80-90% of children are seropositive for VZV by the age of 15 years. In 2-6% of all cases potentially serious complications can occur in previously healthy children and adults. According to the European surveillance network, European population is highly infected by VZV, and vaccine uptake is extremely poor. Routine childhood immunization against varicella may be considered in countries where (1) varicella is relatively important public health and socioeconomic problem; (2) vaccine is affordable; and (3) high and sustained vaccine coverage can be achieved. Even in difficult economic periods, when health care budgets are seriously limited, further resources for primary prevention should be found, which would also enable children from all economic backgrounds to receive vaccination on an equal basis. Ideal reimbursement strategy would be full (100%) coverage by giving two doses for one or more cohorts. If it is not feasible second best option would be a partial reimbursement scheme for every child. In case it could not be reached, reimbursement only for risk groups should be implemented in Hungary (this is already available in Poland). As long-term evidence is not available at the time of registration, health economic modelling is required. Modelling with thorough sensitivity analysis can reduce the uncertainty of reimbursement decisions compared to alternative use of public resources.
Authors and Affiliations
László Szabó, Teresa Jackowska, Zoltán Kaló, Andrea Kulcsár, Zsófia Mészner, Zsuzsanna Molnár, Jacek Wysocki, Peter Wutzler, Judit Kormos-Tasi, Christophe Sauboin
Keywords
Related Articles
- EP ID EP55127
- DOI -
- Views 77
- Downloads 0
Comparative analysis of questionnaires exploring nutritional status and risk of malnutrition in the elderly living in residential care
<b>Aim</b>. Our aim was to compare different validated questionnaires that measure nutritional status and risk of malnutrition in the institutionalized elderly, matching these with data of the...
Medical error in gallbladder cancer treatment – case report, review of literature and legal analysis of the situation
Gallbladder carcinoma is a highly aggressive malignancy. This neoplasm was first time described in 1777. More than 230 years later, the prognosis in gallbladder carcinoma is poor. Appropriate treatment of patients may he...
Najczęstsze błędy w diagnostyce i leczeniu choroby hemoroidalnej
Professional help for visually impaired mothers raising a child
Introduction. The operative laws in Hungary state that each person is entitled to equal treatment, while avoiding strengthening the judgment of one’s state as ’illness’. Professional guidelines do not make it necessary t...
The clinical analysis of antrochoanal polyps in children
<b>Introduction. </b>Antrochoanal polyps (ACPs) occur most commonly in children and young adults. Antrochoanal polyps are associated with chronic sinusitis and/or allergy. The symptoms of ACPs...